Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARQ 531 |
Trade Name | |
Synonyms | ARQ531|ARQ-531|Nemtabrutinib|MK-1026|MK 1026|MK1026 |
Drug Descriptions |
ARQ 531 is an ATP-competitive BTK inhibitor with activity against wild-type BTK and BTK C481S, which may inhibit migration and viability of tumor cells (PMID: 30093506, PMID: 31992353). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | 2095393-15-8 |
NCIT ID | C138066 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARQ 531 | ARQ 531 | 1 | 4 |
ARQ 531 + Rituximab | ARQ 531 Rituximab | 0 | 1 |
ARQ 531 + Venetoclax | ARQ 531 Venetoclax | 0 | 1 |
ARQ 531 + VLS-101 | ARQ 531 VLS-101 | 0 | 1 |